Measuring the Volumes of Hypertrophic Scars and Keloids, Two Specific Kind of Scars, Over Different Points in Time in Patients Who Have Undergone Surgery and Evaluate 3D-cameras As a Possible Measuring and Documenting Tool Including Volumetry
Launched by UNIVERSITY OF ZURICH · Feb 3, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial aims to study two types of scars called hypertrophic scars and keloids, which can develop after surgery. Researchers want to measure the size of these scars over time to see how they change and to test if 3D cameras can be useful tools for accurately measuring and documenting these scars. The trial is currently looking for participants who are at least 18 years old and have these types of scars. If you are interested, you'll need to give your written consent to take part in the study.
If you join this trial, you can expect to have your scars measured at different times, which will help researchers understand how these scars behave over time. Your participation will contribute valuable information that could improve future treatments for people with similar scars. It's important to note that only individuals who are willing to follow the study guidelines and can understand what the study involves will be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients with hypertrophic scars or keloids, written consent to participate in the study, minimum age of 18 years.
- Exclusion Criteria:
- • Absence of written consent, unwillingness to contribute data, inability to understand the study protocol.
- • lack of hypertrophic scars or keloid
About University Of Zurich
The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zürich, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported